Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Alatrofloxacin Mesylate
2. Cp 116,517
3. Cp 116517
4. Cp-116,517
5. Cp-116517
6. Trovan
1. Alatrofloxacin [inn]
2. 146961-76-4
3. 7qvv6i50dt
4. 157182-32-6
5. Alatrofloxacin (inn)
6. 7-((1r,5s,6s)-6-((s)-2-((s)-2-aminopropanamido)propanamido)-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid
7. 7-[(1r,5s)-6-[[(2s)-2-[[(2s)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic Acid
8. Unii-7qvv6i50dt
9. Alatrofloxacin [vandf]
10. Schembl140567
11. Schembl7616277
12. Alatrofloxacin [who-dd]
13. Chembl1201197
14. Dtxsid4057893
15. Chebi:135829
16. Zinc100067477
17. Zinc245224310
18. Db09335
19. Hy-16035
20. L-alaninamide, L-alanyl-n-((1alpha,5alpha,6alpha)-3-(6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl)-3-azabicyclo(310)hex-6-yl)-
21. L-alaninamide, L-alanyl-n-(3-(6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl)-3-azabicyclo(310)hex-6-yl)-, (1alpha,5alpha,6alpha)-
22. Cs-0006126
23. D07562
24. 7-((1r,5s,6s)-6-((s)-2-((s)-2-aminopropionamido)propionamido)-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid
| Molecular Weight | 558.5 g/mol |
|---|---|
| Molecular Formula | C26H25F3N6O5 |
| XLogP3 | -0.2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | 558.18385241 g/mol |
| Monoisotopic Mass | 558.18385241 g/mol |
| Topological Polar Surface Area | 158 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 1080 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
79
PharmaCompass offers a list of Alatrofloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alatrofloxacin manufacturer or Alatrofloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alatrofloxacin manufacturer or Alatrofloxacin supplier.
PharmaCompass also assists you with knowing the Alatrofloxacin API Price utilized in the formulation of products. Alatrofloxacin API Price is not always fixed or binding as the Alatrofloxacin Price is obtained through a variety of data sources. The Alatrofloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alatrofloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alatrofloxacin, including repackagers and relabelers. The FDA regulates Alatrofloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alatrofloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Alatrofloxacin supplier is an individual or a company that provides Alatrofloxacin active pharmaceutical ingredient (API) or Alatrofloxacin finished formulations upon request. The Alatrofloxacin suppliers may include Alatrofloxacin API manufacturers, exporters, distributors and traders.
Alatrofloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alatrofloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alatrofloxacin GMP manufacturer or Alatrofloxacin GMP API supplier for your needs.
A Alatrofloxacin CoA (Certificate of Analysis) is a formal document that attests to Alatrofloxacin's compliance with Alatrofloxacin specifications and serves as a tool for batch-level quality control.
Alatrofloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Alatrofloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alatrofloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Alatrofloxacin EP), Alatrofloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alatrofloxacin USP).
